WuXi PharmaTech (Cayman) Inc. Operating Expenses
WuXi PharmaTech (Cayman) Inc. reported Operating Expenses of $148.01 million for the 12-month period ending 2014-12-31, per its 20-F filed 2015-04-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2015-04-15
| Period end | Operating Expenses 12 month |
|---|---|
| 2014-12-31 | $148.01M 20-F · filed 2015-04-15 |
| 2013-12-31 | $106.32M 20-F · filed 2015-04-15 |
| 2012-12-31 | $93.82M 20-F · filed 2015-04-15 |
| 2011-12-31 | $72.63M 20-F · filed 2014-04-15 |
| 2010-12-31 | $56.09M 20-F · filed 2013-04-17 |
| 2009-12-31 | $56.28M 20-F · filed 2012-04-20 |
| 2008-12-31 | $117.27M 20-F · filed 2011-04-27 |